KURA FY 2011 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena

KURAKura Oncology, Inc.

$792M

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$23,440

Operating Income

-$20,509

Net Income

-$22,395

EPS (Diluted)

$-0.00

Cash Flow

Operating Cash Flow

-$19,244

Free Cash Flow

-$19,244

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$6,720

Total Liabilities

$74,751

Stockholders' Equity

-$68,031

Cash & Equivalents

$4,220

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$23,440	-$20,509	-14.3%
Operating Income	-$20,509	-$41,018	+50.0%
Net Income	-$22,395	-$22,395	+0.0%